(a) Microscopic image and schematic representation of crystal polymorphs obtained via heteroepitaxial growth (α-phase: green; β-phase: red). Polystyrene particles with a diameter of 860 nm were used ...
This research uncovered a previously unknown polymorph (κ-form) of indomethacin, a widely used pain relief and ...
Polymorphs are not mythical, chimeric beasts—they are substances with identical chemical compositions but differing crystal structures that also exhibit different physical and chemical properties.
The transformation of ritonavir form 1 into a less soluble form 2 is the most notorious example of the risks associated with crystal polymorphism in pharmaceuticals. Since then, significant ...
Hosted on MSN
Scientists redesign common deworming drug to kill cancer cells... and it could even prevent the deadly disease
What is being hailed as a 'cancer treatment breakthrough' comes not from a brand-new experimental drug, but from a 40-year-old medicine used to treat worms. Researchers from Johns Hopkins University ...
MADISON, Wis.--(BUSINESS WIRE)--New research by Usona Institute identifies the most favorable environments to achieve consistency and reproducibility of pharmaceutical psilocybin produced at large ...
An inexpensive and reliable method for molecular crystal structure predictions (CSPs) has been developed. The new CSP protocol starts from a two-dimensional graph of crystal’s monomer(s) and utilizes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results